Patent details

EP1368038 Title: MEDICAMENT FOR THE ADMINISTRATION OF AMIFOSTINE AND RELATED COMPOUNDS

Basic Information

Publication number:
EP1368038
PCT Application Number:
PCT/US/2002/002256
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP027134733
PCT Publication Number:
WO/2002/062350
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
MEDICAMENT FOR THE ADMINISTRATION OF AMIFOSTINE AND RELATED COMPOUNDS
French Title of Invention:
MEDICAMENT POUR L'ADMINISTRATION D'AMIFOSTINE ET COMPOSES ASSOCIES
German Title of Invention:
MEDIKAMENT ZUR VERABREICHUNG VON AMIFOSTIN UND VERWANDTEN WIRKSTOFFEN
SPC Number:

Dates

Filing date:
04/02/2002
Grant date:
12/09/2007
EP Publication Date:
12/09/2007
PCT Publication Date:
15/08/2002
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
10/12/2003
EP B1 Publication Date:
12/09/2007
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
04/02/2008
Expiration date:
04/02/2022
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
04/02/2002
 
 

Name:
Medimmune Oncology Inc.
Address:
One Tower Bridge, 100 Front Street, West Conshohocken, PA 19428, United States (US)

Inventor

Name:
STOGNIEW Martin
Address:
United States (US)

Priority

Priority Number:
775540
Priority Date:
05/02/2001
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/66;
Filing date Document type Number of pages